SUPRIYA LIFESCIENCE
|
The Current P/S Ratio of SUPRIYA LIFESCIENCE is 9.89.
| Share Price | ₹1,017.3 | Jun 30,2026 |
| Market Cap | ₹8,189.3 Cr | |
| Sales-TTM | ₹827.9 Cr | TTM-Standalone Results |
| Price/Sales | 9.89x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SUPRIYA LIFESCIENCE
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹8,189.3 Cr] as on Jun 30,2026
(/) Sales [ ₹827.9 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 9.89x ]
Thus, for SUPRIYA LIFESCIENCE , the investors are currently willing to pay '9.89 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SUPRIYA LIFESCIENCE !
The chart below summarizes the trend in P/S Ratio of SUPRIYA LIFESCIENCE over the last five years.
Historical PS (Price/Sales) ratio chart of SUPRIYA LIFESCIENCE
PS Ratio Performance Analysis for SUPRIYA LIFESCIENCE
- SUPRIYA LIFESCIENCE 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 4.79x.
- SUPRIYA LIFESCIENCE 's operated at median p/e ratio of 4.68x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SUPRIYA LIFESCIENCE 's p/e ratio peaked in Mar2025 at 8.48x.
- SUPRIYA LIFESCIENCE 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does SUPRIYA LIFESCIENCE 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SUPRIYA LIFESCIENCE | 827.9 | 9.89 | 8,189.3 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.64 | 446,924.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 16.54 | 174,619.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 11.19 | 156,450.0 |
| CIPLA LTD | 28,162.6 | 4.20 | 118,361.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.36 | 113,253.0 |
| MANKIND PHARMA LTD | 14,277.6 | 7.37 | 105,169.0 |
| LUPIN LTD | 27,958.0 | 3.96 | 110,657.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.09 | 110,942.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.69 | 90,670.9 |
| LAURUS LABS LTD | 6,812.9 | 12.04 | 81,996.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SUPRIYA LIFESCIENCE 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.69x |
| Max industry PS | 16.54x |
| Median industry PS | 7.37x |
| Average industry PS | 7.54x |
You may also like the below Video Courses